Biotechnological approaches to the production of promising plant-derived
anticancer agents: An update and overview
Abstract
The plant kingdom is a rich source of bioactive compounds, many of which
have used since pre-history for their therapeutic properties to treat a
range of illnesses. More recently, some of these metabolites have
attracted attention to their antineoplastic activities to treat various
cancers relying on different mechanisms to kill. Some of these molecules
are glycosides, which have proven useful as anti-cancer agents, namely
podophyllotoxin (PPT) anaryltetralin lignan or alkaloids. There are
three primary forms of alkaloids, such as indole alkaloids (vincristine
and vinblastine from Catharanthus roseus) quinoline alkaloid
(camptothecin from Camptotheca acuminata) and diterpenoid alkaloid
(taxol and it’s analogous from Taxus and Corylus species). This review
considers a variety of plant biotechnology approaches used to enhance
the production of these anticancer molecules in different species. In
this regard, many in vitro culture techniques such as stimulation of
suspension culture and hairy roots are being used to investigate the
effects of plant growth regulators and elicitors on various explants.